Evidence map›Paper›PMID 28592745›Full record

ReviewJournal of clinical and experimental hematopathology : JCEH2017

Clinicopathological features of cryptococcal lymphadenitis and a review of literature.

Keisuke Kawamoto, Hiroaki Miyoshi, Takaharu Suzuki, Reiji Muto, Kyohei Yamada, Eriko Yanagida, Mayuko Koshino, Yuya Sasaki, Jun Takizawa, Hirohito Sone and 3 more

Open access · goldAbstract readCase ReportsReview
In one paragraph

Review in Journal of clinical and experimental hematopathology : JCEH, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. HTLV-1 and Co-infections.Frontiers in medicine · 2022
    Review
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Keisuke KawamotoDepartment of Hematology, Endocrinology and Metabolism, Faculty of Medicine, Niigata University.
Hiroaki MiyoshiDepartment of Pathology, School of Medicine, Kurume University.
Takaharu SuzukiDepartment of Hematology, Endocrinology and Metabolism, Faculty of Medicine, Niigata University.
Reiji MutoDepartment of Pathology, School of Medicine, Kurume University.
Kyohei YamadaDepartment of Pathology, School of Medicine, Kurume University.
Eriko YanagidaDepartment of Pathology, School of Medicine, Kurume University.
Mayuko KoshinoDepartment of Pathology, School of Medicine, Kurume University.
Yuya SasakiDepartment of Pathology, School of Medicine, Kurume University.
Jun TakizawaDepartment of Hematology, Endocrinology and Metabolism, Faculty of Medicine, Niigata University.
Hirohito SoneDepartment of Hematology, Endocrinology and Metabolism, Faculty of Medicine, Niigata University.
Yasuo SugitaDepartment of Pathology, School of Medicine, Kurume University.
Masao SetoDepartment of Pathology, School of Medicine, Kurume University.
Koichi OhshimaDepartment of Pathology, School of Medicine, Kurume University.
Kurume University · JPNiigata University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cryptococcosis is an invasive fungal infection in immunocompromised patients. The clinicopathological characteristics of cryptococcal lymphadenitis are not well known. We analyzed three cases of cryptococcal lymphadenitis and compared their characteristics with those in previous reports. Two patients were human immunodeficiency virus (HIV) carriers, and one patient was a human T-cell leukemia virus type-1 (HTLV-1) carrier. The age of the HTLV-1 carrier with cryptococcosis was much higher than that of the HIV-1 carriers. CD4-positive cell counts in peripheral blood were 5.8/μL (Case 1) and 79.9/μL (Case 2) in the HIV carriers and 3285/μL in the HTLV-1 carrier (Case 3). According to flow cytometric analysis of the lymph nodes of Cases 1, 2, and 3, 50.0%, 87.1%, and 85.9%, respectively, of the T-cells were CD3; 9.8%, 16.3%, and 75.8%, respectively, were CD4; and 35.5%, 77.3%, and 10.2%, respectively, were CD8. Cryptococcus neoformans was detected in tissue culture in all patients. Although gelatinous lesions and numerous fungal cocci were observed in the two HIV patients, the granuloma formation was small. Gelatinous formation and granuloma formation were observed in the HTLV-1 carrier. Necrosis was observed in all cases. In previous reports, granuloma formation, epithelioid cells, and necrotic lesions were observed in most cases. Most of the patients were also immunosuppressed. However, no HTLV-1 carrier was detected. In conclusion, lymphadenopathy in a HTLV-1 carrier may suggest the presence of cryptococcal lymphadenitis. The frequency of cryptococcosis in HTVL-1 carriers may increase with increase in the long-term survival rate of HTLV-1 carriers.

Indexed as

AdultAged, 80 and overBiomarkersBiopsyCD4 Lymphocyte CountColony Count, MicrobialCryptococcosisFemaleHIV InfectionsHTLV-I InfectionsHumansImmunocompromised HostLymphadenitisLymph NodesMalePhenotypeBiomarkersCryptococcal lymphadenitisCryptococcosisHIVHTLV-1Immunocompromised

Identifiers

PMID28592745
PMCPMC6144269
OpenAlexW2624221642

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.